Context Therapeutics Inc. Accrued Liabilities, Current
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Accrued Liabilities, Current $4.43M.
- 2026-03-31: Accrued Liabilities, Current $3.91M.
- 2025-12-31: Accrued Liabilities, Current $5.38M.
- 2025-09-30: Accrued Liabilities, Current $3.20M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $4.43M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $3.91M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $5.38M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $3.20M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.04M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $787.78K 10-Q · filed 2025-05-07 |
| 2024-12-31 | $1.19M 10-K · filed 2026-03-23 |
| 2024-09-30 | $1.20M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $992.83K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $563.06K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $1.81M 10-K · filed 2025-03-20 |
| 2023-09-30 | $2.78M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $2.56M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.99M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $2.22M 10-K · filed 2024-03-21 |
| 2022-09-30 | $2.44M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $2.00M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.06M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $1.21M 10-K · filed 2023-03-22 |
| 2021-09-30 | $1.33M 10-Q · filed 2021-12-02 |
| 2020-12-31 | $955.99K 10-K · filed 2022-03-23 |